Your browser doesn't support javascript.
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults.
Vanshylla, Kanika; Tober-Lau, Pinkus; Gruell, Henning; Münn, Friederike; Eggeling, Ralf; Pfeifer, Nico; Le, N Han; Landgraf, Irmgard; Kurth, Florian; Sander, Leif E; Klein, Florian.
  • Vanshylla K; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.
  • Tober-Lau P; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gruell H; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany.
  • Münn F; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Eggeling R; Methods in Medical Informatics, Department of Computer Science, University of Tübingen, Tübingen, Germany.
  • Pfeifer N; Methods in Medical Informatics, Department of Computer Science, University of Tübingen, Tübingen, Germany; Faculty of Medicine, University of Tübingen, Tübingen, Germany; German Center for Infection Research, Partner Site Tübingen, Tübingen, Germany.
  • Le NH; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Landgraf I; Hausarztpraxis am Agaplesion Bethanien Sophienhaus, Berlin, Germany.
  • Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and Department of Medicine I, University Medic
  • Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Klein F; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne 50931, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne 50931, Germany; German Center for Infection Research, Partner Site B
Lancet Infect Dis ; 22(4): 445-446, 2022 04.
Article in English | MEDLINE | ID: covidwho-1717809
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Antibodies, Viral Topics: Vaccines / Variants Limits: Aged / Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(22)00135-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Antibodies, Viral Topics: Vaccines / Variants Limits: Aged / Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(22)00135-9